Andere talen Renovaro Inc.

Aandelen

RENB

US29350E1047

Geschatte realtime Cboe BZX Andere beurzen 17:21:42 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,66 ^USD	-2,35%		-20,05%	-45,27%

24/04	Renovaro's RenovaroCube wijzigt overeenkomst om 100% belang in Cyclomics te verwerven	MT
18/04	Renovaro Inc. Kondigt Geert Kazemier, MD, PhD, aan als de nieuwe voorzitter van de wetenschappelijke adviesraad	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25/04
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24/04
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24/04
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18/04
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18/04
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	13/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12/03
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	05/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03/03
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	24/02
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	17/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	16/02
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	15/02
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14/02
Renovaro Inc. Announces Board Changes	14/02
Sector Update: Health Care Stocks Gain Late Afternoon	14/02
Sector Update: Health Care	14/02
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report	14/02
Statement of Renovaro Inc	14/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Renovaro Inc.

Aandelen

RENB

US29350E1047

Andere talen

Filters